CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-03 | Herman Alan C. Chief Scientific Officer | Option exercise | +14,166 | $0.42 | $6K | 228,865 |
| 2015-08-03 | Herman Alan C. Chief Scientific Officer | Sale | −14,166 | $34.83 | $493K | 214,699 |
| 2015-08-03 | Herman Alan C. Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −14,166 | 91,360 | ||
| 2015-07-30 | Troendle August J. Director | Sale | −5,249 | $32.22 | $169K | 1,887,243 |
| 2015-07-30 | Troendle August J. Director | Sale | −173,440 | $33.77 | $5.9M | 1,713,803 |
| 2015-07-30 | Troendle August J. Director | Sale | −68,941 | $34.09 | $2.4M | 1,644,862 |
| 2015-07-30 | Troendle August J. Director | Sale | −2,370 | $35.15 | $83K | 1,642,492 |
| 2015-07-30 | Troendle August J. Director | Sale | −1,889 | $32.22 | $61K | 356,539 |
| 2015-07-30 | Troendle August J. Director | Sale | −62,442 | $33.77 | $2.1M | 294,097 |
| 2015-07-30 | Troendle August J. Director | Sale | −24,809 | $34.09 | $846K | 269,288 |
| 2015-07-30 | Troendle August J. Director | Sale | −860 | $35.15 | $30K | 268,428 |
| 2015-06-15 | Troendle August J. Director | Sale | −111,606 | $26.62 | $3.0M | 1,894,868 |
| 2015-06-15 | Troendle August J. Director | Sale | −2,376 | $27.08 | $64K | 1,892,492 |
| 2015-06-12 | Troendle August J. Director | Sale | −134,167 | $26.72 | $3.6M | 2,008,325 |
| 2015-06-12 | Troendle August J. Director | Sale | −1,851 | $27.29 | $51K | 2,006,474 |
| 2015-05-21 | Lanfear Dennis M See Remarks | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2015-04-02 | Lanfear Dennis M See Remarks | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2015-04-02 | Lanfear Dennis M See Remarks | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2015-04-01 | Watler Peter K. Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2015-04-01 | Watler Peter K. Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 |
Page 32 of 39 · 768 trades